Insights for life sciences companies, investors and healthcare professionals
Both Ukraine and Russia are major centres for international clinical research, with many multinational biopharmaceutical clinical trials taking place in these countries. The Russian invasion of Ukraine and the resulting war and sanctions regime have resulted in significant disruption to the conduct of such trials and the availability of medication for trial patients.
During this webinar, John Easton will share insights from his recent research on how this situation is affecting the global biopharmaceutical industry. John will also talk about his experiences of leveraging technology tools to accelerate life sciences dealmaking and improve deal outcomes.
This webinar will be essential viewing for anybody involved in the life sciences industry including healthcare companies, investors in the sector and healthcare professionals. Register today to book your place on our webinar, as well as the opportunity to put your questions to our expert.
Key Learning Objectives:
- How the war in Ukraine is affecting clinical trials
- Regulatory responses to the disruption of clinical trials
- Actions that trial sponsors are taking to try to mitigate the impact of clinical trial disruption
- Technology tools for life sciences dealmaking
